Individualization of anti-VEGF treatment protocols can reduce treatment burden on patients with age-related macular degeneration ... hemorrhages or fluid seen on OCT images.

The 2024 American Academy of Ophthalmology (AAO) Preferred Practice Patterns provide guidance for physicians about best practices in the treatment of age-related macular degeneration (AMD).

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Purpose To analyse the morphological characteristics of eyes with neovascular age-related macular degeneration (AMD ... years of follow-up after initiating anti-VEGF therapy. Spectral-domain optical ...

CAMBRIDGE - Joan W. Miller, MD—the David Glendenning Cogan Professor of Ophthalmology and Chair of Ophthalmology at Harvard Medical School and Chair of Ophthalmology at Massachusetts Eye and Ear and ...

Background/aims Real-life anti-vascular endothelial growth factor (VEGF) therapy use in patients with wet age-related macular degeneration (wAMD ... 12 months in France between September 2006 and ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...